Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IPa-Gastric: Intraperitoneal Paclitaxel in Gastric Cancer with Peritoneal Metastases
NCT07304271Phase 3Recruiting
- Start
- Nov 2025
- Primary completion
- Jan 2031
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of paclitaxel in gastric cancer (GC). Started Nov 2025; status: recruiting.
02
Drugs
paclitaxel
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT07304271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07304271.